Lemon balm and viral infections: Exploring its potential as a natural antiviral therapy

Melissa officinalis, commonly known as lemon balm, has been widely recognized for its medicinal properties, particularly its antiviral potential. Traditionally used for stress relief, digestive issues, and sleep enhancement, modern research has uncovered its ability to combat viral infections, including SARS-CoV-2, herpes simplex virus (HSV), influenza, and human immunodeficiency virus (HIV). This review evaluates the antiviral mechanisms of lemon balm and its bioactive compounds, such as rosmarinic acid and essential oils.

Studies indicate that Melissa officinalis inhibits viral replication, prevents viral attachment to host cells, and modulates immune responses to reduce infection severity. In the case of HSV-1 and HSV-2, lemon balm extract interferes with viral glycoproteins, preventing cell penetration and reducing viral load. Research has also demonstrated its potential to suppress HIV replication and hinder influenza virus proliferation by disrupting viral enzymes. Furthermore, computational analyses suggest that phytochemicals in lemon balm may inhibit SARS-CoV-2 spike protein interactions, making it a promising complementary therapy in managing COVID-19.

Beyond direct antiviral effects, lemon balm exhibits strong antioxidant and anti-inflammatory properties, which play a crucial role in mitigating virus-induced oxidative stress and inflammation. These benefits make it a candidate for reducing the impact of viral infections on immune and metabolic health.

While preliminary data support its antiviral efficacy, further clinical trials are needed to validate its effectiveness in human subjects. Given its accessibility, affordability, and safety, Melissa officinalis holds promise as a natural adjunctive therapy for viral infections, warranting continued research into its pharmaceutical applications.